ENTITY

Revolution Medicines (RVMD US)

13
Analysis
Health CareUnited States
Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.
more
16 Jul 2024 14:00

Revolution Medicines Inc.: Focus on Novel Combo-Therapeutic Approaches and Broader Genetic Mutations & Other Major Developments - Financial Forecasts

Revolution Medicines has posted the financial and operational updates for the first quarter of 2024, emphasizing significant advancements in its...

Logo
195 Views
Share
24 Apr 2024 17:00

Revolution Medicines Inc.: Initiation Of Coverage - Progression Of Clinical Development Programs & Other Major Drivers

Revolution Medicines reported a decent set of earnings call for the fourth quarter and full year of 2023. Throughout the year, Revolution made...

Logo
217 Views
Share
10 Aug 2023 12:11

Smartkarma Webinar | High Conviction Trade Ideas in the US

Join us as we go live with Smartkarma Insight Provider Andrei Zakharov as he discusses some U.S. SaaS stocks, crypto mining companies, and his high...

Logo
2.7k Views
Share
06 Aug 2023 01:39

2023 High Conviction Update: Revolution Medicines, RVMD/EQRx Deal Adds $1B+ Of Capital

RVMD/EQRx deal will add $1B+ of capital and help to support a rich clinical development pipeline and combination strategies for RAS-addicted cancers.

Logo
402 Views
Share
25 Nov 2022 01:30

2023 High Conviction: Revolution Medicines – Cracking The KRAS In Cancer

Oncology-focused unicorn Revolution Medicines is our high-risk/high-reward conviction idea for 2023 as we see room for further gains among select...

Logo
515 Views
Share
x